Mebendazole Study Against Hookworm Infections in Children and Adolescents in Ghana

Inclusion Criteria

• •1. Male or female, aged 6 to 18 years, inclusive, at the time of randomization.
• •2. Written informed consent signed by at least one parent and/or legally acceptable representative (as defined by local law); and assent by participant.
• •3. Able and willing to be examined by a study health care provider at the beginning of the study.
• •4. Able and willing to provide one stool sample at the beginning (baseline) and one sample approximately three weeks after treatment (follow-up).
• •5. Positive for hookworm eggs in the stool (two Kato-Katz thick smear slides with more than one hookworm egg) at baseline.